Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin vs Tranexamic Acid and Etamsylate vs Placebo for Blood Loss in C-Section
NCT05273632Completed
- Sponsor
- Egymedicalpedia
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Oxytocin, TXA + Etamsylate and Placebo (3 arms). Primary endpoint: Blood loss during and after cesarean delivery at 2 hours. Started Mar 2022; status: completed.
02
Drugs
oxytocintranexamic acidetamsylate
Beyond the preview
Go deeper on NCT05273632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273632.